UAB "Vox pharmaceutica" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 209,943 |
| 69,981 |
| 2,936 |
| 2,496 |
| 832 |
| 46.48 |
| 1.19 |
| -75,178 |
| 342,635 |
| 0 |
| 267,457 |
| 2024 |
|---|
| 22,240 |
| 7,413 |
| -1,981 |
| -1,981 |
| -660 |
| 69.11 |
| -8.91 |
| -77,159 |
| 0 |
| 0 |
| 229,094 |
| 2025 |
|---|
| 9,645 |
| 3,215 |
| 825 |
| 693 |
| 231 |
| 65.25 |
| 7.19 |
| -76,466 |
| 305,174 |
| 0 |
| 228,708 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 9,645 |
| 3,215 |
| 825 |
| 693 |
| 231 |
| 65.25 |
| 7.19 |
| -76,466 |
| 305,174 |
| 0 |
| 228,708 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
9,645 €-57 % *
Sales per employee (€)
3,215 €-57 % *
Profit before tax (€)
825 €142 % *
Net Profit (€)
693 €135 % *
Profit per employee (€)
231 €135 % *
Total profitability (%)
65.25 %-5.59 % *
Net profitability (%)
7.19 %180.70 % *
Equity (€)
-76,466 €1 % *
Amounts Payable And Liabilities (€)
305,174 €- *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
228,708 €0 % *
